Allworth Financial LP - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Allworth Financial LP ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$46,576
+23.4%
1,234
+48.9%
0.00%
Q2 2023$37,750
-4.6%
829
-15.1%
0.00%
Q1 2023$39,585
+18.6%
976
+49.0%
0.00%
Q4 2022$33,379
-12.2%
655
-7.1%
0.00%
Q3 2022$38,000
-34.5%
705
-22.0%
0.00%
-100.0%
Q2 2022$58,000
+56.8%
904
+90.7%
0.00%
Q1 2022$37,000
-31.5%
474
-24.9%
0.00%
-100.0%
Q4 2021$54,000
-11.5%
631
-17.2%
0.00%0.0%
Q3 2021$61,000
+10.9%
762
+11.2%
0.00%0.0%
Q2 2021$55,000
+223.5%
685
+242.5%
0.00%
Q1 2021$17,000
+54.5%
200
+39.9%
0.00%
Q4 2020$11,000
-8.3%
1430.0%0.00%
Q3 2020$12,000
-55.6%
143
-54.3%
0.00%
-100.0%
Q2 2020$27,000
+125.0%
313
+118.9%
0.00%
Q1 2020$12,0000.0%1430.0%0.00%
Q4 2019$12,000
-7.7%
1430.0%0.00%
Q3 2019$13,000
+8.3%
1430.0%0.00%
Q2 2019$12,0000.0%1430.0%0.00%
-100.0%
Q1 2019$12,000
+33.3%
1430.0%0.00%
Q4 2018$9,000
-18.2%
1430.0%0.00%
Q3 2018$11,000
+37.5%
143
+30.0%
0.00%
Q2 2018$8,000
+14.3%
110
+6.8%
0.00%
-100.0%
Q1 2018$7,0000.0%103
-1.0%
0.00%0.0%
Q4 2017$7,000
+16.7%
104
+3.0%
0.00%
Q3 2017$6,0000.0%1010.0%0.00%
-100.0%
Q2 2017$6,000
+20.0%
1010.0%0.00%
Q1 2017$5,000
+25.0%
1010.0%0.00%
Q4 2016$4,000
-20.0%
1010.0%0.00%
-100.0%
Q3 2016$5,0000.0%1010.0%0.00%0.0%
Q2 2016$5,000
+25.0%
1010.0%0.00%0.0%
Q1 2016$4,0000.0%1010.0%0.00%0.0%
Q4 2015$4,000
+33.3%
1010.0%0.00%0.0%
Q3 2015$3,000
-57.1%
1010.0%0.00%
-50.0%
Q2 2015$7,0000.0%1010.0%0.00%
-33.3%
Q1 2015$7,0001010.00%
Other shareholders
BAXTER INTL INC shareholders Q4 2020
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders